Family Support Programs for Preventing Substance Use Disorders
Trial Summary
What is the purpose of this trial?
Primary Objective: Conduct a rigorous evaluation of a prevention-based intervention designed to mitigate the harms of adverse childhood experiences (ACEs) exposure and prevent future ACEs, substance use, and overdose within 36 communities experiencing a disproportionate burden of substance use and ACEs. The study has three aims: (1) use a cluster randomized controlled trial to test effectiveness of the Strengthening Families Program (SFP) + Family Advocate (FA) intervention on substance use, overdose, and ACEs in 18 communities compared with SFP-only in 18 communities; (2) conduct a robust process evaluation informed by the Consolidated Framework for Implementation Research (CFIR) to explore implementation barriers and facilitators; and (3) conduct a cost evaluation to accurately estimate the costs required to implement SFP and SFP+FA and assess the cost-effectiveness of SFP+FA relative to SFP alone. Findings will provide a roadmap about the best ways to help disproportionately affected communities prevent substance use, overdose, and ACEs.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the Strengthening Families Program treatment for preventing substance use disorders?
Research shows that the Strengthening Families Program (SFP) is effective in preventing substance misuse by strengthening family protective factors. It has been successfully adapted and implemented in various countries, demonstrating positive results across different cultural groups and age ranges.12345
Is the Strengthening Families Program safe for humans?
How is the Strengthening Families Program treatment different from other treatments for preventing substance use disorders?
The Strengthening Families Program is unique because it focuses on strengthening family relationships and skills to prevent substance use, rather than directly targeting the individual. It can be delivered in group settings or through a home-use DVD, making it flexible and accessible for families. Additionally, it has been culturally adapted for diverse populations, ensuring its effectiveness across different cultural groups.12358
Research Team
Phillip W. Graham, DrPH
Principal Investigator
RTI International
Dallas J Elgin, PhD
Principal Investigator
RTI International
Eligibility Criteria
This trial is for communities heavily impacted by substance use and adverse childhood experiences (ACEs). It aims to evaluate a program designed to prevent substance misuse and reduce the harms of ACEs. Specific eligibility criteria are not provided, suggesting that it may be open to various participants within these communities.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Families participate in the Strengthening Families Program with or without Family Advocate support over a 10- to 14-week period
Follow-up
Participants are monitored for substance use, ACEs, and service utilization through surveys and assessments
Treatment Details
Interventions
- Strengthening Families Program (Behavioral Intervention)
- Strengthening Families Program + Family Advocate (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
RTI International
Lead Sponsor
RWJBarnabas Health Institute for Prevention and Recovery
Collaborator
New Jersey Prevention Network
Collaborator